Elixher Uncategorized Chinese biotechs pursue Hong Kong IPOs to fuel next stage of growth – FirstWord Pharma

Chinese biotechs pursue Hong Kong IPOs to fuel next stage of growth – FirstWord Pharma

fertility hormone. Bao said that last September it licensed Chinese rights to SJ02 to a “global leader in fertility treatments” as part of a deal …

Related Post